Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 895519-91-2
2. Flumatinib (mesylate)
3. 95y8l63nbc
4. N-(6-methyl-5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)pyridin-3-yl)-4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamide Methanesulfonate
5. 895519-91-2 (mesylate)
6. Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-n-[6-methyl-5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-3-pyridinyl]-3-(trifluoromethyl)-, Monomethanesulfonate (9ci)
7. Hhgv678 Mesylate
8. N-(6-methyl-5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)pyridin-3-yl)-4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamide Mesylate
9. Unii-95y8l63nbc
10. Hh-gv-678 Mesylate
11. Schembl4889246
12. Chembl3901539
13. Dtxsid70237780
14. Bcp08647
15. Ex-a2059
16. Vkb51991
17. Flumatinib Mesylate [who-dd]
18. Mfcd28053502
19. Cs-1826
20. Da-33624
21. Hy-13905
22. Methanesulfonic Acid;4-[(4-methylpiperazin-1-yl)methyl]-n-[6-methyl-5-[(4-pyridin-3-ylpyrimidin-2-yl)amino]pyridin-3-yl]-3-(trifluoromethyl)benzamide
23. Ft-0752643
24. E73439
25. Q27271825
26. Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-n-(6-methyl-5-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-3-pyridinyl)-3-(trifluoromethyl)-, Methanesulfonate (1:1)
27. Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-n-(6-methyl-5-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-3-pyridinyl)-3-(trifluoromethyl)-, Monomethanesulfonate
Molecular Weight | 658.7 g/mol |
---|---|
Molecular Formula | C30H33F3N8O4S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 7 |
Exact Mass | 658.22975722 g/mol |
Monoisotopic Mass | 658.22975722 g/mol |
Topological Polar Surface Area | 162 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 934 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
55
PharmaCompass offers a list of Flumatinib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flumatinib Mesylate manufacturer or Flumatinib Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flumatinib Mesylate manufacturer or Flumatinib Mesylate supplier.
PharmaCompass also assists you with knowing the Flumatinib Mesylate API Price utilized in the formulation of products. Flumatinib Mesylate API Price is not always fixed or binding as the Flumatinib Mesylate Price is obtained through a variety of data sources. The Flumatinib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Flumatinib Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flumatinib Mesylate, including repackagers and relabelers. The FDA regulates Flumatinib Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flumatinib Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Flumatinib Mesylate supplier is an individual or a company that provides Flumatinib Mesylate active pharmaceutical ingredient (API) or Flumatinib Mesylate finished formulations upon request. The Flumatinib Mesylate suppliers may include Flumatinib Mesylate API manufacturers, exporters, distributors and traders.
Flumatinib Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flumatinib Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flumatinib Mesylate GMP manufacturer or Flumatinib Mesylate GMP API supplier for your needs.
A Flumatinib Mesylate CoA (Certificate of Analysis) is a formal document that attests to Flumatinib Mesylate's compliance with Flumatinib Mesylate specifications and serves as a tool for batch-level quality control.
Flumatinib Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Flumatinib Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flumatinib Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Flumatinib Mesylate EP), Flumatinib Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flumatinib Mesylate USP).